Dialogue meeting on a scheme for centres for clinical health research

The Research Council invites representatives of research institutions, regional health authorities, trade and industry, and other relevant actors to a dialogue meeting to provide input on how best to design a scheme for centres for clinical health research.
Quality and concentration are key research policy objectives. At the Research Council this is manifested in, among other things, the schemes for Centres of Excellence (SFF), Centres for Research-driven Innovation (SFI) and Centres for Environment-friendly Energy Research (FME). The Health&Care21 strategy document recommends establishing a scheme for centres for clinical health research, similar to the existing Centre for Environment-friendly Energy Research (FME) scheme. The Research Council has been asked to develop a model for such a scheme. The strategy document proposes to allocate long-term funding to the centres (tentatively NOK 10–15 million per year for five years with a possible three-year extension). The centres are to carry out research of exceptionally high-quality designed to solve identified, fundamental problems related to clinical treatment in a cooperative effort between research institutions, regional health authorities, and trade and industry across different subject areas and disciplines. International cooperation must be given high priority. Thematic freedom, scientific breadth and relevance to the healthcare field will create a framework for a sound competitive arena that awards funding for centres that satisfy stringent quality requirements. The centres for health research must conduct high-quality research of relevance for the specialist and/or municipal health care services. In particular, we are seeking input on the following: Institutional affiliation and composition of the centres: host institutions, partners. Organisation of the centres: advantages and disadvantages of physical and virtual centres. Financing of the centres: financial framework for the centres, the level of own financing, what should be included in the framework? How can cooperation with the industry be organised? How can international cooperation be organised? The Health&Care21 strategy document states that research at the centres must solve identified, fundamental problems related to clinical treatment. What does this mean? How can centres relevant for the municipal health care services be targeted and organised? What will be typical success criteria for the centres? Future trends in clinical studies. For example, how will personalised medicine affect clinical studies in the future? To register or obtain more information, click here (in Norwegian only).
Published Sep. 13, 2016 6:33 PM - Last modified Sep. 13, 2016 6:37 PM